Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Lessons from global materiovigilance systems: What India can learn?

PMID: 41694722 · 2026

JournalPerspectives in clinical research
Year2026
PMID41694722

Abstract

Medical devices are indispensable in modern healthcare, playing a crucial role in diagnosing, treating, and managing various medical conditions. While these devices offer significant benefits, they also pose potential risks due to defects, malfunctions, or adverse events, which can lead to serious patient harm. To mitigate these risks, materiovigilance - the systematic monitoring, detection, assessment, and prevention of adverse events related to medical devices - is essential for ensuring their

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.